Ranbaxy Laboratories Ltd articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2013/05/20 12:22
2013/05/20 12:22
2d
A pharmaceutical manufacturer has pleaded guilty to felony charges that it distributed adulterated drugs in the United States, agreeing to pay $500 million in fines and settlement claims that are...
2013/05/20 12:22
2013/05/20 12:22
Latest videos
2013/05/20 12:22
2013/05/20 12:22
Latest from Twitter
2013/05/19 17:00
2013/05/19 17:00
3d
POSTED: Friday, May 17, 2013, 9:32 AM Ranbaxy Laboratories, Ltd., is an India-based pharmaceutical company with a U.S. subsidiary, Ranbaxy USA Inc., headquartered in Parsippany, N.J. Ranbaxy...
2013/05/14 11:39
2013/05/14 11:39
8d
Ranbaxy announces conclusion of previously disclosed U.S. justice department probe Gurgaon, May 14 : Ranbaxy Laboratories Ltd. has announced that a previously disclosed investigation by the U.S....
2013/05/14 08:51
2013/05/14 08:51
9d
Dow slips on Monday as investors hold back The Dow slipped Monday despite new data showing Americans increased retail spending in April. But it wasn’t enough to spur money managers into the buying...
2013/05/13 19:20
2013/05/13 19:20
9d
Generic drugmaker Ranbaxy Laboratories Ltd pleaded guilty on Monday to felony charges related to drug safety and will pay $500 million in civil and criminal fines under the settlement agreement with...
2013/05/13 17:22
2013/05/13 17:22
9d
GURGAON, India--(BUSINESS WIRE)--Ranbaxy Laboratories Ltd. (RLL, NSE: RANBAXY, BSE: 500359) (“Ranbaxy”), today announced that a previously disclosed investigation by the U.S. Department of Justice...
2013/05/02 12:06
2013/05/02 12:06
20d
Earnings excluding some costs declined to $960 million, or $1.12 a share, from $1.3 billion, or $1.47, a year earlier, the Petach Tikva, Israel-based company said in a statement today. Profit beat the...
2013/04/29 16:29
2013/04/29 16:29
23d
The company is seeking approval for its drug elvitegravir for people with HIV, the virus that causes AIDS, who have already been treated with other products. The drug blocks the enzyme integrase which...
2013/04/24 06:07
2013/04/24 06:07
29d
Earnings excluding some costs increased to $3.25 billion from $3.04 billion a year earlier, the Basel, Switzerland-based company said in a statement today. Analysts predicted profit of $3.12 billion,...